Skip to main content
Journal cover image

Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection

Publication ,  Conference
Grimley, MS; Marón, GM; Prasad, VK; Jacobsohn, DA; Young, J-AH; Chittick, G; Brundage, TM; Momméja-Marin, H
Published in: Biology of Blood and Marrow Transplantation
February 2015

Duke Scholars

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

February 2015

Volume

21

Issue

2

Start / End Page

S108 / S109

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Grimley, M. S., Marón, G. M., Prasad, V. K., Jacobsohn, D. A., Young, J.-A., Chittick, G., … Momméja-Marin, H. (2015). Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection. In Biology of Blood and Marrow Transplantation (Vol. 21, pp. S108–S109). Elsevier BV. https://doi.org/10.1016/j.bbmt.2014.11.136
Grimley, Michael S., Gabriela M. Marón, Vinod K. Prasad, David A. Jacobsohn, Jo-Anne H. Young, Greg Chittick, Thomas M. Brundage, and Hervé Momméja-Marin. “Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection.” In Biology of Blood and Marrow Transplantation, 21:S108–9. Elsevier BV, 2015. https://doi.org/10.1016/j.bbmt.2014.11.136.
Grimley MS, Marón GM, Prasad VK, Jacobsohn DA, Young J-AH, Chittick G, et al. Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2015. p. S108–9.
Grimley, Michael S., et al. “Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection.” Biology of Blood and Marrow Transplantation, vol. 21, no. 2, Elsevier BV, 2015, pp. S108–09. Crossref, doi:10.1016/j.bbmt.2014.11.136.
Grimley MS, Marón GM, Prasad VK, Jacobsohn DA, Young J-AH, Chittick G, Brundage TM, Momméja-Marin H. Preliminary Results from the AdVise Study Evaluating Brincidofovir (CMX001, BCV) for the Treatment of Disseminated and High-Risk Adenovirus (AdV) Infection. Biology of Blood and Marrow Transplantation. Elsevier BV; 2015. p. S108–S109.
Journal cover image

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

February 2015

Volume

21

Issue

2

Start / End Page

S108 / S109

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences